Consistently been ranked top or is among the top ranking worldwidely!

Eugonia's Medically Assisted Reproduction Unit consistently ranks among the best globally for helping people achieve successful pregnancies through assisted reproduction techniques. Our success rates, denoting the proportion of outcomes per embryo transfer, are among the highest worldwide.

What makes us stand out is our deep understanding of reproductive science, personalized treatment plans for each patient, and use of the latest methods in infertility treatment. We're transparent about our process – we don't pick and choose patients based on factors like how long they've been trying to conceive or the method used for fertilization.

To help people make informed choices, we share our success rates in three key areas: live births, clinical pregnancies, and positive pregnancy tests. By comparing our rates with others globally, people can see why Eugonia is a top choice for reproductive assistance.

See and compare our rates with the corresponding international ones. Comparison is the best indicator of unit selection.

We list the success rates of Eugonia in 3 tables:

See more:

• How pregnancy rates are presented
• European pregnancy rates
• What is IVF

Pioneers of success internationally

Eugonia is an ART Unit with stable and top pregnancy rates. These rates put us in the highest positions worldwide, regarding live births and also positive pregnancy tests.

How pregnancy rates are presented

Success rates are presented as:
•    Positive pregnancy tests (biochemical pregnancies)
•    Clinical pregnancies (embryos with heart beat at 6 weeks)
•    On going pregnancies (>12 weeks)
•    Live births
either per embryo transfer or per treatment cycle.
The presentation of results can also be based on special parameters, like:
•    Age of woman, e.g. pregnancy success rates for women below 40 and over 40, or for women <35, 35-40, 40-43, ΄>43 years of age.
•    The treatment method: in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) transfer of cryopreserved embryos (FER), preimplantation genetic diagnosis (PGD, PGS), oocyte or embryo donation (OD, ED), in vitro maturation oocytes (IVM), etc.
•    Cause of infertility, etc.

National register

The national register of pregnancy rates of all IVF Units in Greece would provide with candidate couples with a reliable selection criterion. This already happens in several countries (USA, UK, France, Germany, Australia). In Greece, the function of the independent authority of Assisted Reproduction has been temporarily withheld. One of its duties was to collate and publish pregnancy rates of ART Units in Greece. It is anticipated that this national register will soon come into force and will become a formal conformation of success rates for each Unit so that candidate couples can compare Greek and foreign ART Units.

Our research profile leads to increased pregnancy rates

Every day, new knowledge is accumulated from scientists worldwide in order to increase pregnancy rates. The publication of a study in a medical journal contributes, apart from the recognition of the researchers, to better and sounder knowledge of the subject. Exposure of a manuscript to peer review requires constant update and knowledge of the literature, and also an extensive database for the statistical analysis of data. These are part of evidence-based medicine but are not practiced by everyone.

We present the pregnancy rates following IVF in European countries in 2009. The results were collated from the European IVF Monitoring Programme, EIM) that operates under the European Society of Human Reproduction and Embryology (ESHRE). The results were published in Human Reproduction, official journal of ESHRE (EIM, A.P. Ferraretti et al., Hum Reprod. 2013 July;28 (9):2318-2331, 2013).
See the publication

This is the 13th   annual report of ESHRE, while the nine previous ones concern statistical data form the years 2001-2009. The data for 2009 were collected from 34 European countries and 1005 clinics. The quality of data differs from country to country and is not always complete.

For Greece, the data are derived from 4 IVF Units from a total of 50 and are collected by Prof. Basil Tarlatzis, Professor of Obstetrics-Gynaecology and Human Reproduction at Aristotle University of Thessaloniki.

Eugonia (with its present scientific composition) has participated fully in this annual registration of data since 1997.

We present three tables summarizing clinical pregnancies and live births rates resulting from IVF (Table 1), ICSI (Table 2) and Frozen embryos (Table 3).

*IVF = in vitro fertilization

Note: Pregnancy rates of European countries are calculated over the total of treated women without age classification.

For IVF, the average clinical pregnancy rate is 28,9% per aspiration, ranging from 18.9 % to 45,8 % between different countries.

*ICSI = intracytoplasmic sperm injection

Note: Pregnancy rates of European countries are calculated over the total of treated women without age classification.

For ICSI, the average clinical pregnancy rate is 28,7% per egg aspiration, ranging from 22.8 % to 42.5 % between different countries.

*FET = Frozen embryo transfer

Note: Pregnancy rates of European countries are calculated over the total of treated women without age classification.

In the case of transfer of frozen embryos (FET*) the average clinical pregnancy rate is 20.9% per embryo transfer, ranging from 12.5% to 33.3% between different countries.

A very important distinction was made by Eugonia Assisted Reproduction Unit for the proposal submitted to the SME Instruments of the HORIZON 2020 program in Phase 1 regarding the use of AI in the evaluation of embryos, further strengthening its presence in the Hellenic Medical Area as well as Internationally.

This suggestion has been refined in all assessment categories in one of the most demanding programs where less than 5% of participants manage to distinguish themselves.

HORIZON 2020's "SME Instruments" is the largest European Research and Innovation Program available, with available funding amounting to € 80 billion, for the seven-year period 2014-2020.

Continue

Dr. George Lainas, gynecologist at Eugonia, will be the coordinator of ESHRE and specifically of the Special Interest Group "Reproductive Endocrinology" for the next two years (2019-2021).

ESHRE (European Society of Human Reproduction and Embryology) is a global organization that defines developments in the wider field of Assisted Reproduction worldwide.

This distinction is the international recognition of Eugonia's scientific and clinical work over the last 20 years of its action, which  aims  at the benefit of every couple who trusts our team to fulfill their dream of having a child.

One of our chief gynecologist G.Lainas was elected as coordinator of European Society of Human Reproduction and Embryology (ESHRE).

His election took place in the business meeting of Special Interest Group, Reproductive Endocrinology (SIG RE) of ESHRE, during the annual meeting. The conference took place in Barcelona in July of 2018 with 12.500 registrations from all over the world.

Dr. G.Lainas has an active part in ESHRE, as he is a member in two guidance groups: a) GDG on Ovarian Stimulation in IVF/ICSI and b) ART Clinical Performance Indicators.

See the members of ESHRE SIG Reproductive Endrocrinology

See George Lainas Curriculum Vitae

Dr G. Lainas was elected for the first time as Junior Deputy of Special Interest Group of Reproductive Endocrinology of ESHRE in 2015 , while he holds the post of Senior Deputy since 2017. This is a unique post of global exposure offered to internationally acclaimed scientists and clinicians, who steer the developments of Reproductive Medicine at an international scale.

See the members of ESHRE SIG Reproductive Endrocrinology

See George Lainas Curriculum Vitae

Dr. G.Lainas has an active part in ESHRE, as he is a member in two guidance groups: a) GDG on Ovarian Stimulation in IVF/ICSI and b) ART Clinical Performance Indicators.

The first one is in charge of the guideline development group of ovarian stimulation. This group consists of 15 members and all of them are researchers with a range of scientific work, professors in major European universities and world-class figures in IVF and reproductive endocrinology.

Continue

Eugonia is the first Greek IVF Clinic certified for ISO EN 15224:2012 in the field of health, regarding patient’s safety, treatment effectiveness and quality system improvement.

Eugonia has permanent collaboration with other Universities in Greece and abroad, in order to perform pioneering researches which will improve the clinical outcomes.

These Faculties are: Aristotle University of Thessaloniki, University of Nottingham, University of New South Wales, Barts and the London NHS Trust,

The scientific team of Eugonia has developed an innovative treatment for severe Ovarian Hyperstimulation Syndrome, eliminating the risk of complications (according to 5 published studies of our team). This treatment has been established internationally as the tertiary level for the management of OHSS, and is considered as the only available treatment of the syndrome worldwide. 
See more

88% per blastocyst  transferred, for women below  35 years old
See more